Elite Pharmaceuticals Inc /NV/ SEC filings ELTP

Elite Pharmaceuticals Inc /NV/ has 1,000 filings in SEC EDGAR's recent list, going back to Apr 5, 2005. Its latest annual report, Form 10-K, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on March 31.

Elite Pharmaceuticals Inc /NV/ SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 3, 2026 Oct 28, 2026
4 Insider transaction Oct 19, 2026 Oct 9, 2026
4 Insider transaction Sep 10, 2026 Aug 19, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K/A Amended current report
Regulation FD disclosure
Aug 11, 2026 Aug 10, 2026
8-K Current report
Regulation FD disclosure
Aug 10, 2026 Aug 10, 2026
8-K Current report
Regulation FD disclosure
Aug 4, 2026 Aug 4, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jun 29, 2026 Jun 29, 2026
10-K Annual report Jun 29, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
Jun 23, 2026 Jun 23, 2026
8-K Current report
Regulation FD disclosure
Jun 15, 2026 Jun 15, 2026
8-K Current report
Regulation FD disclosure
Jun 1, 2026 May 29, 2026
UPLOAD Letter from the SEC Apr 14, 2026 —
8-K Current report
Regulation FD disclosure
Apr 2, 2026 Apr 2, 2026
CORRESP Letter to the SEC Mar 18, 2026 —
UPLOAD Letter from the SEC Mar 4, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 17, 2026 Feb 17, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Feb 11, 2026 Feb 11, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K/A Amended current report
Regulation FD disclosure
Nov 12, 2025 Nov 10, 2025
8-K Current report
Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
4 Insider transaction Oct 3, 2025 Oct 2, 2025
4 Insider transaction Aug 26, 2025 Aug 22, 2025
144 Notice of proposed sale Aug 22, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Aug 8, 2025 Aug 8, 2025
4 Insider transaction Jul 25, 2025 Jul 10, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 8, 2025 Jul 8, 2025
144 Notice of proposed sale Jul 8, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
10-K Annual report Jun 30, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
Jun 23, 2025 Jun 23, 2025
8-K Current report
Regulation FD disclosure
Jun 16, 2025 Jun 16, 2025
8-K Current report
Regulation FD disclosure
Apr 30, 2025 Apr 30, 2025
8-K Current report
Regulation FD disclosure
Mar 3, 2025 Feb 28, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 13, 2025 Feb 13, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Dec 26, 2024 Dec 26, 2024
8-K Current report
Regulation FD disclosure
Dec 2, 2024 Dec 2, 2024
8-K Current report
Regulation FD disclosure
Nov 18, 2024 Nov 18, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
4 Insider transaction Oct 28, 2024 Oct 23, 2024
144 Notice of proposed sale Oct 23, 2024 —
8-K Current report
Regulation FD disclosure
Oct 10, 2024 Oct 10, 2024
8-K Current report
Regulation FD disclosure
Oct 7, 2024 Oct 7, 2024
8-K Current report
Regulation FD disclosure
Aug 27, 2024 Aug 27, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
S-8 Employee stock plan registration Jul 1, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Jul 1, 2024 Jul 1, 2024
10-K Annual report Jul 1, 2024 Mar 31, 2024
8-K Current report
Material agreement
Jun 21, 2024 Jun 17, 2024
8-K Current report
Auditor change
Jun 5, 2024 Jun 1, 2024
8-K Current report
Regulation FD disclosure
May 20, 2024 May 20, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4/A Filing Apr 2, 2024 Dec 29, 2023
S-8 Employee stock plan registration Mar 28, 2024 —
S-8 Employee stock plan registration Mar 28, 2024 —
UPLOAD Letter from the SEC Feb 28, 2024 —
CORRESP Letter to the SEC Feb 20, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 14, 2024 Feb 14, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Jan 22, 2024 —
4 Insider transaction Dec 29, 2023 Dec 29, 2023
8-K Current report
Regulation FD disclosure
Dec 26, 2023 Dec 26, 2023
8-K Current report
Other events
Dec 12, 2023 Dec 12, 2023
4 Insider transaction Nov 27, 2023 Nov 22, 2023
4 Insider transaction Nov 27, 2023 Nov 22, 2023
4 Insider transaction Nov 27, 2023 Nov 22, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Regulation FD disclosure
Sep 25, 2023 Sep 25, 2023
8-K Current report
Material agreement, Officer or director change
Sep 7, 2023 Sep 7, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-K/A Amended annual report Jul 31, 2023 Mar 31, 2023
8-K Current report
Auditor change
Jul 17, 2023 Jul 11, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jun 29, 2023 Jun 29, 2023
10-K Annual report Jun 29, 2023 Mar 31, 2023
4 Insider transaction Jun 26, 2023 Jan 3, 2023
3 Initial insider ownership May 8, 2023 May 1, 2023
8-K Current report
Material agreement, Officer or director change
May 3, 2023 May 3, 2023
8-K Current report
Regulation FD disclosure
Apr 20, 2023 Apr 20, 2023
8-K Current report
Officer or director change
Feb 28, 2023 Feb 28, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 14, 2023 Feb 14, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Dec 22, 2022 Dec 22, 2022
8-K Current report
Material agreement
Nov 28, 2022 Nov 28, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 15, 2022 Nov 15, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
4 Insider transaction Nov 14, 2022 Nov 10, 2022
8-K Current report
Agreement ended
Nov 10, 2022 Nov 10, 2022
8-K Current report
Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
3 Initial insider ownership Sep 13, 2022 Sep 6, 2022
8-K Current report
Material agreement, Officer or director change
Sep 7, 2022 Sep 7, 2022
4 Insider transaction Aug 29, 2022 Aug 28, 2022
4 Insider transaction Aug 29, 2022 Aug 28, 2022
4 Insider transaction Aug 29, 2022 Aug 28, 2022
8-K Current report
Agreement ended
Aug 26, 2022 Aug 26, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
4 Insider transaction Jul 7, 2022 May 16, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jun 29, 2022 Jun 29, 2022
10-K Annual report Jun 29, 2022 Mar 31, 2022
8-K Current report
Regulation FD disclosure
Jun 29, 2022 Jun 27, 2022
3 Initial insider ownership Jun 3, 2022 May 16, 2022
8-K Current report
Material agreement, Officer or director change
May 11, 2022 May 11, 2022
8-K Current report
Officer or director change
Apr 18, 2022 Apr 18, 2022
8-K Current report
Regulation FD disclosure
Apr 4, 2022 Apr 4, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Feb 15, 2022 Feb 14, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Material agreement
Dec 9, 2021 Dec 9, 2021
8-K Current report
Material agreement
Dec 2, 2021 Dec 2, 2021
8-K Current report
Material agreement
Dec 2, 2021 Dec 2, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 15, 2021 Aug 16, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 16, 2021 Aug 16, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
4 Insider transaction Jul 7, 2021 May 17, 2021
4 Insider transaction Jul 1, 2021 Jun 30, 2021
4 Insider transaction Jul 1, 2021 Jun 30, 2021
4 Insider transaction Jul 1, 2021 Jun 30, 2021
10-K/A Amended annual report Jun 22, 2021 Mar 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jun 14, 2021 Jun 14, 2021
10-K Annual report Jun 14, 2021 Mar 31, 2021
3 Initial insider ownership May 19, 2021 May 17, 2021
8-K Current report
Other events
May 5, 2021 May 5, 2021
8-K Current report
Material agreement, Officer or director change
Apr 29, 2021 Apr 26, 2021
8-K Current report
Officer or director change
Apr 12, 2021 Apr 7, 2021
UPLOAD Letter from the SEC Mar 12, 2021 —
CORRESP Letter to the SEC Feb 22, 2021 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 16, 2021 Feb 16, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
UPLOAD Letter from the SEC Feb 9, 2021 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 16, 2020 Nov 16, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
SC 13D/A Amended ownership over 5% (active) Sep 1, 2020 —
8-K Current report
Unregistered share sale
Aug 27, 2020 Aug 24, 2020
4 Insider transaction Aug 26, 2020 Aug 24, 2020
4 Insider transaction Aug 24, 2020 Aug 20, 2020
4 Insider transaction Aug 24, 2020 Aug 20, 2020
4 Insider transaction Aug 24, 2020 Aug 20, 2020
4 Insider transaction Aug 24, 2020 Aug 20, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Aug 17, 2020 Aug 14, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
8-K/A Amended current report Jul 31, 2020 Aug 1, 2013
EFFECT Filing Jul 27, 2020 —
424B3 Prospectus Jul 27, 2020 —
CORRESP Letter to the SEC Jul 23, 2020 —
UPLOAD Letter from the SEC Jul 22, 2020 —
S-3 Shelf registration Jul 15, 2020 —
D Filing Jul 13, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Jul 9, 2020 Jul 8, 2020
4 Insider transaction Jul 6, 2020 Jun 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jun 29, 2020 Jun 29, 2020
10-K Annual report Jun 29, 2020 Mar 31, 2020
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 24, 2020 Jun 23, 2020
DEFA14A Additional proxy material May 11, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 23, 2020
8-K Current report
Bylaw or fiscal year change
Apr 23, 2020 Apr 22, 2020
PRE 14A Preliminary proxy statement Apr 17, 2020 Apr 17, 2020
8-K Current report
Material agreement
Feb 26, 2020 Feb 20, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Feb 10, 2020 Feb 10, 2020
10-Q Quarterly report Feb 10, 2020 Dec 31, 2019
8-K Current report
Regulation FD disclosure
Dec 12, 2019 Dec 11, 2019
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Dec 5, 2019 Dec 4, 2019
8-K Current report
Material agreement
Nov 19, 2019 Nov 13, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
DEFA14A Additional proxy material Oct 18, 2019 —
DEF 14A Proxy statement Oct 10, 2019 Dec 4, 2019
PRE 14A Preliminary proxy statement Sep 27, 2019 Dec 4, 2019
8-K Current report
Regulation FD disclosure
Sep 12, 2019 Sep 10, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2019 Aug 9, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Jun 24, 2019 Jun 21, 2019
10-K Annual report Jun 21, 2019 Mar 31, 2019
NT 10-K Notification of late filing Jun 14, 2019 Mar 31, 2019
8-K Current report
Material agreement
Mar 11, 2019 Mar 7, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Feb 12, 2019 Feb 11, 2019
10-Q Quarterly report Feb 11, 2019 Dec 31, 2018
8-K Current report
Regulation FD disclosure
Jan 3, 2019 Dec 28, 2018
8-K Current report
Regulation FD disclosure
Dec 10, 2018 Nov 7, 2018
8-K Current report
Regulation FD disclosure
Nov 20, 2018 Nov 16, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Nov 9, 2018 Nov 9, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
8-K Current report
Regulation FD disclosure
Nov 5, 2018 Nov 1, 2018
8-K Current report
Regulation FD disclosure
Oct 23, 2018 Oct 22, 2018
10-Q/A Amended quarterly report Oct 17, 2018 Sep 30, 2013
8-K Current report
Regulation FD disclosure
Sep 18, 2018 Sep 17, 2018
CT ORDER Filing Sep 6, 2018 —
8-K/A Amended current report Aug 30, 2018 Aug 1, 2013

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ELTP (OTC)
Fiscal year ends
March 31
Incorporated in
NJ
Headquarters
Northvale, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1053369
Former names
ELITE PHARMACEUTICALS INC /DE/ (until Feb 8, 2012)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.